VANDA PHARMACEUTICALS INC. Operating Leases, Future Minimum Payments, Due Thereafter
VANDA PHARMACEUTICALS INC. (VNDA) had Operating Leases, Future Minimum Payments, Due Thereafter of $10.67 million as of 2018-12-31, per its 10-K filed 2020-02-26.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter · last filed 2020-02-26
- 2018-12-31: Operating Leases, Future Minimum Payments, Due Thereafter $10.67M.
- 2018-09-30: Operating Leases, Future Minimum Payments, Due Thereafter $13.09M.
- 2018-06-30: Operating Leases, Future Minimum Payments, Due Thereafter $13.09M.
- 2018-03-31: Operating Leases, Future Minimum Payments, Due Thereafter $13.10M.
| Period end | Operating Leases, Future Minimum Payments, Due Thereafter |
|---|---|
| 2018-12-31 | $10.67M 10-K · filed 2020-02-26 |
| 2018-09-30 | $13.09M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $13.09M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $13.10M 10-Q · filed 2018-05-02 |
| 2017-12-31 | $8.47M 10-K · filed 2018-02-15 |
| 2017-09-30 | $10.66M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $10.66M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $10.66M 10-Q · filed 2017-05-03 |
| 2016-12-31 | $10.66M 10-K · filed 2017-02-17 |
| 2016-09-30 | $12.83M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $12.83M 10-Q · filed 2016-07-28 |
| 2016-03-31 | $5.43M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $5.43M 10-K · filed 2016-02-12 |
| 2015-09-30 | $7.08M 10-Q · filed 2015-11-04 |
| 2015-06-30 | $7.08M 10-Q · filed 2015-07-31 |
| 2015-03-31 | $7.08M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $7.08M 10-K · filed 2015-03-13 |
| 2014-09-30 | $8.70M 10-Q · filed 2014-10-27 |
| 2014-06-30 | $8.70M 10-Q · filed 2014-08-08 |
| 2014-03-31 | $8.70M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $5.16M 10-K · filed 2014-02-25 |
| 2013-09-30 | $6.32M 10-Q · filed 2013-11-08 |
| 2013-06-30 | $6.32M 10-Q · filed 2013-07-31 |
| 2013-03-31 | $6.32M 10-Q · filed 2013-05-10 |
| 2012-12-31 | $6.32M 10-K · filed 2013-02-26 |
| 2012-09-30 | $7.45M 10-Q · filed 2012-11-08 |
| 2012-06-30 | $7.45M 10-Q · filed 2012-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |